GT Biopharma (GTBP) Payables (2009 - 2026)
GT Biopharma (GTBP) recorded Payables of $1.02 million in Q2 2026, down 30.4% from $1.46 million a year earlier but up 301.6% from the prior quarter.
Powered by 
Analysis
GT Biopharma (GTBP) Payables (2009 - 2026) Analysis & Trends
At the end of FY2025, GT Biopharma reported Payables of $748,000, down 80.6% from FY2024.
- Annual Payables has a five-year compound annual growth rate of -19.7% (FY2020 to FY2025).
- Across earlier years, Payables came in at $3.85 million in FY2024 (-11.0%), $4.33 million in FY2023 (+33.2%), $3.25 million in FY2022 (-65.0%) and $9.29 million in FY2021 (+314.1%).
- Quarterly Payables has ranged from $253,000 in Q1 2026 to $9.29 million in Q4 2021 over the past five years.
- On a year-over-year basis, Payables has declined for nine consecutive quarters, with an average decline of 43.9% over the last eight quarters.
- Peak year-over-year performance for Payables in the last five years was growth of 314.1% in Q4 2021, against a decline of 89.4% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $253,000 (Q1 2026), $748,000 (Q4 2025) and $913,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 5.79 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 18.17 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 34.43 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 7.17 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | -25.19 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 2.95 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 934.00 Mn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 4.07 Bn |
| 10 | GT Biopharma | 6.65 Mn | -16.58 Mn | - | 1.02 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.02 Mn |
| Mar 31, 2026 | 253,000.00 |
| Dec 31, 2025 | 748,000.00 |
| Sep 30, 2025 | 913,000.00 |
| Jun 30, 2025 | 1.46 Mn |
| Mar 31, 2025 | 2.38 Mn |
| Dec 31, 2024 | 3.85 Mn |
| Sep 30, 2024 | 2.61 Mn |
| Jun 30, 2024 | 1.72 Mn |
| Mar 31, 2024 | 3.21 Mn |
| Dec 31, 2023 | 4.33 Mn |
| Sep 30, 2023 | 3.97 Mn |
| Jun 30, 2023 | 3.50 Mn |
| Mar 31, 2023 | 3.13 Mn |
| Dec 31, 2022 | 3.25 Mn |
| Sep 30, 2022 | 3.33 Mn |
| Jun 30, 2022 | 7.26 Mn |
| Mar 31, 2022 | 8.11 Mn |
| Dec 31, 2021 | 9.29 Mn |
| Sep 30, 2021 | 4.33 Mn |
API Access
GT Biopharma Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=GTBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "GTBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=GTBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();